Global Non-Invasive Blood Glucose Monitoring Devices

Non-Invasive Blood Glucose Monitoring Devices Comprehensive Study by Type (Spectroscopy Monitoring, Optical Coherence Tomography Monitoring, Electromagnetic Monitoring, Polarimetry Monitoring, Others), Application (Hospitals, Clinics, Home Care Settings, Other), Modality (Wearable Blood Glucose Monitoring Systems, Non-wearable /Table top Blood Glucose Monitoring Systems) Players and Region - Global Market Outlook to 2024

Non-Invasive Blood Glucose Monitoring Devices Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Non-Invasive Blood Glucose Monitoring Devices Market Overview:
Non-invasive blood glucose monitoring devices is a medical device that is used to measures blood glucose levels in patients suffering from diabetes, without puncturing the skin, or causing pain or trauma.Glucose monitoring devices market is driving due to the need of an economic, compact, painless and convenience for the patients to use. Some of the key players profiled in the study are Abbott Laboratories (United States), Medtronic Public Limited (United States), Nemaura Medical, Inc. (United Kingdom), Echo Therapeutics, Inc. (United States), Medical Wireless Sensing Ltd. (MediWiSe) (United Kingdom), DexCom, Inc. (United States), Integrity Applications, Inc. (Israel), Cnoga Medical Ltd (Israel) and LifeScan Inc. (Johnson & Johnson (United States).

On the basis of geography, the market of Non-Invasive Blood Glucose Monitoring Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Modality, the sub-segment i.e. Wearable Blood Glucose Monitoring Systems will boost the Non-Invasive Blood Glucose Monitoring Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Market Drivers
  • Increasing Incidence of Diabetes Especially Among Obese Population
  • Increase in Number of Collaboration and Funding To Support Diabetes Research

Market Trend
  • Development and Innovation In Non Invasive Blood Glucose Monitoring Devices

Restraints
  • High Cost of Blood Glucose Monitoring Devices and Rise in Economic Burden for Diabetes
  • Poor Reimbursement for Blood Glucose Monitoring System and Supplies

Opportunities
  • Rising Demand For Smart and Bluetooth enabled Blood Glucose Meter

Challenges
  • Stringent Regulations and Registration Process
  • Complex Procedures to Calibrate Glucose Measurement Results Prior To Use



WHO aims to stimulate and support the adoption of effective measures for the surveillance, prevention and control of diabetes and its complications, particularly in low and middle-income countries. It provides guidelines for prevention of major non communicable diseases including diabetes. It also develops norms and standards for diabetes diagnosis and care.

Target Audience:
Blood Glucose Monitoring Systems and Related Devices Manufacturers, Suppliers and Distributors of Blood Glucose Monitoring Systems, Hospitals, Diagnostic Centers, Homecare Service Providers, and Medical Colleges, Teaching Hospitals and Academic Medical Centers, Government Bodies/Municipal Corporations, Business Research and Consulting Service Providers and Venture Capitalists

Major Objectives Focused through this Study
• To define, describe, and forecast the Global Non-Invasive Blood Glucose Monitoring Devices market on the basis of product [Spectroscopy Monitoring, Optical Coherence Tomography Monitoring, Electromagnetic Monitoring, Polarimetry Monitoring and Others] , application [Hospitals, Clinics, Home Care Settings and Other], key regions and end user
• To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
• To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
• Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
• To provide market size for various segments of the Non-Invasive Blood Glucose Monitoring Devices market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
• To strategically profile the key players and analyzing their market shares and core competencies in the Non-Invasive Blood Glucose Monitoring Devices industry
• To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Cercacor (United States) and OrSense Ltd. (Isreal).
** Confirmation on availability of data would be informed prior purchase

While framing the research framework, major and emerging players operating in the Non-Invasive Blood Glucose Monitoring Devices market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.

Report Objectives / Segmentation Covered

By Type
  • Spectroscopy Monitoring
  • Optical Coherence Tomography Monitoring
  • Electromagnetic Monitoring
  • Polarimetry Monitoring
  • Others
By Application
  • Hospitals
  • Clinics
  • Home Care Settings
  • Other
By Modality
  • Wearable Blood Glucose Monitoring Systems
  • Non-wearable /Table top Blood Glucose Monitoring Systems

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Diabetes Especially Among Obese Population
      • 3.2.2. Increase in Number of Collaboration and Funding To Support Diabetes Research
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulations and Registration Process
      • 3.3.2. Complex Procedures to Calibrate Glucose Measurement Results Prior To Use
    • 3.4. Market Trends
      • 3.4.1. Development and Innovation In Non Invasive Blood Glucose Monitoring Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Non-Invasive Blood Glucose Monitoring Devices, by Type, Application, Modality and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Non-Invasive Blood Glucose Monitoring Devices (Value)
      • 5.2.1. Global Non-Invasive Blood Glucose Monitoring Devices by: Type (Value)
        • 5.2.1.1. Spectroscopy Monitoring
        • 5.2.1.2. Optical Coherence Tomography Monitoring
        • 5.2.1.3. Electromagnetic Monitoring
        • 5.2.1.4. Polarimetry Monitoring
        • 5.2.1.5. Others
      • 5.2.2. Global Non-Invasive Blood Glucose Monitoring Devices by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Home Care Settings
        • 5.2.2.4. Other
      • 5.2.3. Global Non-Invasive Blood Glucose Monitoring Devices by: Modality (Value)
        • 5.2.3.1. Wearable Blood Glucose Monitoring Systems
        • 5.2.3.2. Non-wearable /Table top Blood Glucose Monitoring Systems
      • 5.2.4. Global Non-Invasive Blood Glucose Monitoring Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Non-Invasive Blood Glucose Monitoring Devices (Volume)
      • 5.3.1. Global Non-Invasive Blood Glucose Monitoring Devices by: Type (Volume)
        • 5.3.1.1. Spectroscopy Monitoring
        • 5.3.1.2. Optical Coherence Tomography Monitoring
        • 5.3.1.3. Electromagnetic Monitoring
        • 5.3.1.4. Polarimetry Monitoring
        • 5.3.1.5. Others
      • 5.3.2. Global Non-Invasive Blood Glucose Monitoring Devices by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Home Care Settings
        • 5.3.2.4. Other
      • 5.3.3. Global Non-Invasive Blood Glucose Monitoring Devices by: Modality (Volume)
        • 5.3.3.1. Wearable Blood Glucose Monitoring Systems
        • 5.3.3.2. Non-wearable /Table top Blood Glucose Monitoring Systems
      • 5.3.4. Global Non-Invasive Blood Glucose Monitoring Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Non-Invasive Blood Glucose Monitoring Devices (Price)
      • 5.4.1. Global Non-Invasive Blood Glucose Monitoring Devices by: Type (Price)
  • 6. Non-Invasive Blood Glucose Monitoring Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Abbott Laboratories (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic Public Limited (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Nemaura Medical, Inc. (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Echo Therapeutics, Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medical Wireless Sensing Ltd. (MediWiSe) (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. DexCom, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Integrity Applications, Inc. (Israel)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cnoga Medical Ltd (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. LifeScan Inc. (Johnson & Johnson (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Non-Invasive Blood Glucose Monitoring Devices Sale, by Type, Application, Modality and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Non-Invasive Blood Glucose Monitoring Devices (Value)
      • 7.2.1. Global Non-Invasive Blood Glucose Monitoring Devices by: Type (Value)
        • 7.2.1.1. Spectroscopy Monitoring
        • 7.2.1.2. Optical Coherence Tomography Monitoring
        • 7.2.1.3. Electromagnetic Monitoring
        • 7.2.1.4. Polarimetry Monitoring
        • 7.2.1.5. Others
      • 7.2.2. Global Non-Invasive Blood Glucose Monitoring Devices by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Home Care Settings
        • 7.2.2.4. Other
      • 7.2.3. Global Non-Invasive Blood Glucose Monitoring Devices by: Modality (Value)
        • 7.2.3.1. Wearable Blood Glucose Monitoring Systems
        • 7.2.3.2. Non-wearable /Table top Blood Glucose Monitoring Systems
      • 7.2.4. Global Non-Invasive Blood Glucose Monitoring Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Non-Invasive Blood Glucose Monitoring Devices (Volume)
      • 7.3.1. Global Non-Invasive Blood Glucose Monitoring Devices by: Type (Volume)
        • 7.3.1.1. Spectroscopy Monitoring
        • 7.3.1.2. Optical Coherence Tomography Monitoring
        • 7.3.1.3. Electromagnetic Monitoring
        • 7.3.1.4. Polarimetry Monitoring
        • 7.3.1.5. Others
      • 7.3.2. Global Non-Invasive Blood Glucose Monitoring Devices by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Home Care Settings
        • 7.3.2.4. Other
      • 7.3.3. Global Non-Invasive Blood Glucose Monitoring Devices by: Modality (Volume)
        • 7.3.3.1. Wearable Blood Glucose Monitoring Systems
        • 7.3.3.2. Non-wearable /Table top Blood Glucose Monitoring Systems
      • 7.3.4. Global Non-Invasive Blood Glucose Monitoring Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Non-Invasive Blood Glucose Monitoring Devices (Price)
      • 7.4.1. Global Non-Invasive Blood Glucose Monitoring Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Non-Invasive Blood Glucose Monitoring Devices: by Type(USD Million)
  • Table 2. Non-Invasive Blood Glucose Monitoring Devices Spectroscopy Monitoring , by Region USD Million (2013-2018)
  • Table 3. Non-Invasive Blood Glucose Monitoring Devices Optical Coherence Tomography Monitoring , by Region USD Million (2013-2018)
  • Table 4. Non-Invasive Blood Glucose Monitoring Devices Electromagnetic Monitoring , by Region USD Million (2013-2018)
  • Table 5. Non-Invasive Blood Glucose Monitoring Devices Polarimetry Monitoring , by Region USD Million (2013-2018)
  • Table 6. Non-Invasive Blood Glucose Monitoring Devices Others , by Region USD Million (2013-2018)
  • Table 7. Non-Invasive Blood Glucose Monitoring Devices: by Application(USD Million)
  • Table 8. Non-Invasive Blood Glucose Monitoring Devices Hospitals , by Region USD Million (2013-2018)
  • Table 9. Non-Invasive Blood Glucose Monitoring Devices Clinics , by Region USD Million (2013-2018)
  • Table 10. Non-Invasive Blood Glucose Monitoring Devices Home Care Settings , by Region USD Million (2013-2018)
  • Table 11. Non-Invasive Blood Glucose Monitoring Devices Other , by Region USD Million (2013-2018)
  • Table 12. Non-Invasive Blood Glucose Monitoring Devices: by Modality(USD Million)
  • Table 13. Non-Invasive Blood Glucose Monitoring Devices Wearable Blood Glucose Monitoring Systems , by Region USD Million (2013-2018)
  • Table 14. Non-Invasive Blood Glucose Monitoring Devices Non-wearable /Table top Blood Glucose Monitoring Systems , by Region USD Million (2013-2018)
  • Table 15. South America Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2013-2018)
  • Table 16. South America Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 17. South America Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 18. South America Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 19. Brazil Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 20. Brazil Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 21. Brazil Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 22. Argentina Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 23. Argentina Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 24. Argentina Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 25. Rest of South America Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 26. Rest of South America Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 27. Rest of South America Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 28. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2013-2018)
  • Table 29. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 30. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 31. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 32. China Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 33. China Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 34. China Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 35. Japan Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 36. Japan Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 37. Japan Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 38. India Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 39. India Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 40. India Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 41. South Korea Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 42. South Korea Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 43. South Korea Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 44. Taiwan Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 45. Taiwan Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 46. Taiwan Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 47. Australia Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 48. Australia Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 49. Australia Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 50. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 51. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 52. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 53. Europe Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2013-2018)
  • Table 54. Europe Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 55. Europe Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 56. Europe Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 57. Germany Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 58. Germany Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 59. Germany Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 60. France Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 61. France Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 62. France Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 63. Italy Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 64. Italy Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 65. Italy Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 66. United Kingdom Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 67. United Kingdom Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 68. United Kingdom Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 69. Netherlands Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 70. Netherlands Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 71. Netherlands Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 72. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 73. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 74. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 75. MEA Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2013-2018)
  • Table 76. MEA Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 77. MEA Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 78. MEA Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 79. Middle East Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 80. Middle East Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 81. Middle East Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 82. Africa Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 83. Africa Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 84. Africa Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 85. North America Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2013-2018)
  • Table 86. North America Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 87. North America Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 88. North America Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 89. United States Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 90. United States Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 91. United States Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 92. Canada Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 93. Canada Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 94. Canada Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 95. Mexico Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2013-2018)
  • Table 96. Mexico Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2013-2018)
  • Table 97. Mexico Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2013-2018)
  • Table 98. Non-Invasive Blood Glucose Monitoring Devices Sales: by Type(K Units)
  • Table 99. Non-Invasive Blood Glucose Monitoring Devices Sales Spectroscopy Monitoring , by Region K Units (2013-2018)
  • Table 100. Non-Invasive Blood Glucose Monitoring Devices Sales Optical Coherence Tomography Monitoring , by Region K Units (2013-2018)
  • Table 101. Non-Invasive Blood Glucose Monitoring Devices Sales Electromagnetic Monitoring , by Region K Units (2013-2018)
  • Table 102. Non-Invasive Blood Glucose Monitoring Devices Sales Polarimetry Monitoring , by Region K Units (2013-2018)
  • Table 103. Non-Invasive Blood Glucose Monitoring Devices Sales Others , by Region K Units (2013-2018)
  • Table 104. Non-Invasive Blood Glucose Monitoring Devices Sales: by Application(K Units)
  • Table 105. Non-Invasive Blood Glucose Monitoring Devices Sales Hospitals , by Region K Units (2013-2018)
  • Table 106. Non-Invasive Blood Glucose Monitoring Devices Sales Clinics , by Region K Units (2013-2018)
  • Table 107. Non-Invasive Blood Glucose Monitoring Devices Sales Home Care Settings , by Region K Units (2013-2018)
  • Table 108. Non-Invasive Blood Glucose Monitoring Devices Sales Other , by Region K Units (2013-2018)
  • Table 109. Non-Invasive Blood Glucose Monitoring Devices Sales: by Modality(K Units)
  • Table 110. Non-Invasive Blood Glucose Monitoring Devices Sales Wearable Blood Glucose Monitoring Systems , by Region K Units (2013-2018)
  • Table 111. Non-Invasive Blood Glucose Monitoring Devices Sales Non-wearable /Table top Blood Glucose Monitoring Systems , by Region K Units (2013-2018)
  • Table 112. South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2013-2018)
  • Table 113. South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 114. South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 115. South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 116. Brazil Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 117. Brazil Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 118. Brazil Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 119. Argentina Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 120. Argentina Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 121. Argentina Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 122. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 123. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 124. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 125. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2013-2018)
  • Table 126. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 127. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 128. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 129. China Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 130. China Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 131. China Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 132. Japan Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 133. Japan Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 134. Japan Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 135. India Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 136. India Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 137. India Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 138. South Korea Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 139. South Korea Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 140. South Korea Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 141. Taiwan Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 142. Taiwan Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 143. Taiwan Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 144. Australia Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 145. Australia Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 146. Australia Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 147. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 148. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 149. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 150. Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2013-2018)
  • Table 151. Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 152. Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 153. Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 154. Germany Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 155. Germany Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 156. Germany Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 157. France Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 158. France Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 159. France Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 160. Italy Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 161. Italy Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 162. Italy Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 163. United Kingdom Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 164. United Kingdom Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 165. United Kingdom Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 166. Netherlands Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 167. Netherlands Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 168. Netherlands Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 169. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 170. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 171. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 172. MEA Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2013-2018)
  • Table 173. MEA Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 174. MEA Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 175. MEA Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 176. Middle East Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 177. Middle East Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 178. Middle East Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 179. Africa Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 180. Africa Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 181. Africa Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 182. North America Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2013-2018)
  • Table 183. North America Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 184. North America Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 185. North America Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 186. United States Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 187. United States Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 188. United States Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 189. Canada Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 190. Canada Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 191. Canada Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 192. Mexico Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2013-2018)
  • Table 193. Mexico Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2013-2018)
  • Table 194. Mexico Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2013-2018)
  • Table 195. Non-Invasive Blood Glucose Monitoring Devices: by Type(USD/Units)
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Company Basic Information, Sales Area and Its Competitors
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Non-Invasive Blood Glucose Monitoring Devices: by Type(USD Million)
  • Table 206. Non-Invasive Blood Glucose Monitoring Devices Spectroscopy Monitoring , by Region USD Million (2019-2024)
  • Table 207. Non-Invasive Blood Glucose Monitoring Devices Optical Coherence Tomography Monitoring , by Region USD Million (2019-2024)
  • Table 208. Non-Invasive Blood Glucose Monitoring Devices Electromagnetic Monitoring , by Region USD Million (2019-2024)
  • Table 209. Non-Invasive Blood Glucose Monitoring Devices Polarimetry Monitoring , by Region USD Million (2019-2024)
  • Table 210. Non-Invasive Blood Glucose Monitoring Devices Others , by Region USD Million (2019-2024)
  • Table 211. Non-Invasive Blood Glucose Monitoring Devices: by Application(USD Million)
  • Table 212. Non-Invasive Blood Glucose Monitoring Devices Hospitals , by Region USD Million (2019-2024)
  • Table 213. Non-Invasive Blood Glucose Monitoring Devices Clinics , by Region USD Million (2019-2024)
  • Table 214. Non-Invasive Blood Glucose Monitoring Devices Home Care Settings , by Region USD Million (2019-2024)
  • Table 215. Non-Invasive Blood Glucose Monitoring Devices Other , by Region USD Million (2019-2024)
  • Table 216. Non-Invasive Blood Glucose Monitoring Devices: by Modality(USD Million)
  • Table 217. Non-Invasive Blood Glucose Monitoring Devices Wearable Blood Glucose Monitoring Systems , by Region USD Million (2019-2024)
  • Table 218. Non-Invasive Blood Glucose Monitoring Devices Non-wearable /Table top Blood Glucose Monitoring Systems , by Region USD Million (2019-2024)
  • Table 219. South America Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 220. South America Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 221. South America Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 222. South America Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 223. Brazil Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 224. Brazil Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 225. Brazil Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 226. Argentina Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 227. Argentina Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 228. Argentina Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 229. Rest of South America Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 230. Rest of South America Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 231. Rest of South America Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 232. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 233. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 234. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 235. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 236. China Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 237. China Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 238. China Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 239. Japan Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 240. Japan Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 241. Japan Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 242. India Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 243. India Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 244. India Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 245. South Korea Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 246. South Korea Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 247. South Korea Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 248. Taiwan Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 249. Taiwan Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 250. Taiwan Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 251. Australia Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 252. Australia Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 253. Australia Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 254. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 255. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 256. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 257. Europe Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 258. Europe Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 259. Europe Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 260. Europe Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 261. Germany Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 262. Germany Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 263. Germany Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 264. France Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 265. France Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 266. France Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 267. Italy Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 268. Italy Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 269. Italy Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 270. United Kingdom Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 271. United Kingdom Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 272. United Kingdom Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 273. Netherlands Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 274. Netherlands Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 275. Netherlands Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 276. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 277. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 278. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 279. MEA Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 280. MEA Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 281. MEA Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 282. MEA Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 283. Middle East Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 284. Middle East Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 285. Middle East Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 286. Africa Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 287. Africa Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 288. Africa Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 289. North America Non-Invasive Blood Glucose Monitoring Devices, by Country USD Million (2019-2024)
  • Table 290. North America Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 291. North America Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 292. North America Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 293. United States Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 294. United States Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 295. United States Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 296. Canada Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 297. Canada Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 298. Canada Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 299. Mexico Non-Invasive Blood Glucose Monitoring Devices, by Type USD Million (2019-2024)
  • Table 300. Mexico Non-Invasive Blood Glucose Monitoring Devices, by Application USD Million (2019-2024)
  • Table 301. Mexico Non-Invasive Blood Glucose Monitoring Devices, by Modality USD Million (2019-2024)
  • Table 302. Non-Invasive Blood Glucose Monitoring Devices Sales: by Type(K Units)
  • Table 303. Non-Invasive Blood Glucose Monitoring Devices Sales Spectroscopy Monitoring , by Region K Units (2019-2024)
  • Table 304. Non-Invasive Blood Glucose Monitoring Devices Sales Optical Coherence Tomography Monitoring , by Region K Units (2019-2024)
  • Table 305. Non-Invasive Blood Glucose Monitoring Devices Sales Electromagnetic Monitoring , by Region K Units (2019-2024)
  • Table 306. Non-Invasive Blood Glucose Monitoring Devices Sales Polarimetry Monitoring , by Region K Units (2019-2024)
  • Table 307. Non-Invasive Blood Glucose Monitoring Devices Sales Others , by Region K Units (2019-2024)
  • Table 308. Non-Invasive Blood Glucose Monitoring Devices Sales: by Application(K Units)
  • Table 309. Non-Invasive Blood Glucose Monitoring Devices Sales Hospitals , by Region K Units (2019-2024)
  • Table 310. Non-Invasive Blood Glucose Monitoring Devices Sales Clinics , by Region K Units (2019-2024)
  • Table 311. Non-Invasive Blood Glucose Monitoring Devices Sales Home Care Settings , by Region K Units (2019-2024)
  • Table 312. Non-Invasive Blood Glucose Monitoring Devices Sales Other , by Region K Units (2019-2024)
  • Table 313. Non-Invasive Blood Glucose Monitoring Devices Sales: by Modality(K Units)
  • Table 314. Non-Invasive Blood Glucose Monitoring Devices Sales Wearable Blood Glucose Monitoring Systems , by Region K Units (2019-2024)
  • Table 315. Non-Invasive Blood Glucose Monitoring Devices Sales Non-wearable /Table top Blood Glucose Monitoring Systems , by Region K Units (2019-2024)
  • Table 316. South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2019-2024)
  • Table 317. South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 318. South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 319. South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 320. Brazil Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 321. Brazil Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 322. Brazil Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 323. Argentina Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 324. Argentina Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 325. Argentina Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 326. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 327. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 328. Rest of South America Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 329. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2019-2024)
  • Table 330. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 331. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 332. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 333. China Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 334. China Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 335. China Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 336. Japan Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 337. Japan Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 338. Japan Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 339. India Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 340. India Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 341. India Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 342. South Korea Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 343. South Korea Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 344. South Korea Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 345. Taiwan Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 346. Taiwan Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 347. Taiwan Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 348. Australia Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 349. Australia Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 350. Australia Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 351. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 352. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 353. Rest of Asia-Pacific Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 354. Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2019-2024)
  • Table 355. Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 356. Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 357. Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 358. Germany Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 359. Germany Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 360. Germany Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 361. France Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 362. France Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 363. France Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 364. Italy Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 365. Italy Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 366. Italy Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 367. United Kingdom Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 368. United Kingdom Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 369. United Kingdom Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 370. Netherlands Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 371. Netherlands Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 372. Netherlands Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 373. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 374. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 375. Rest of Europe Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 376. MEA Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2019-2024)
  • Table 377. MEA Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 378. MEA Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 379. MEA Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 380. Middle East Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 381. Middle East Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 382. Middle East Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 383. Africa Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 384. Africa Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 385. Africa Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 386. North America Non-Invasive Blood Glucose Monitoring Devices Sales, by Country K Units (2019-2024)
  • Table 387. North America Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 388. North America Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 389. North America Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 390. United States Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 391. United States Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 392. United States Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 393. Canada Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 394. Canada Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 395. Canada Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 396. Mexico Non-Invasive Blood Glucose Monitoring Devices Sales, by Type K Units (2019-2024)
  • Table 397. Mexico Non-Invasive Blood Glucose Monitoring Devices Sales, by Application K Units (2019-2024)
  • Table 398. Mexico Non-Invasive Blood Glucose Monitoring Devices Sales, by Modality K Units (2019-2024)
  • Table 399. Non-Invasive Blood Glucose Monitoring Devices: by Type(USD/Units)
  • Table 400. Research Programs/Design for This Report
  • Table 401. Key Data Information from Secondary Sources
  • Table 402. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Non-Invasive Blood Glucose Monitoring Devices: by Type USD Million (2013-2018)
  • Figure 5. Global Non-Invasive Blood Glucose Monitoring Devices: by Application USD Million (2013-2018)
  • Figure 6. Global Non-Invasive Blood Glucose Monitoring Devices: by Modality USD Million (2013-2018)
  • Figure 7. South America Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 8. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 9. Europe Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 10. MEA Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 11. North America Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 12. Global Non-Invasive Blood Glucose Monitoring Devices: by Type K Units (2013-2018)
  • Figure 13. Global Non-Invasive Blood Glucose Monitoring Devices: by Application K Units (2013-2018)
  • Figure 14. Global Non-Invasive Blood Glucose Monitoring Devices: by Modality K Units (2013-2018)
  • Figure 15. South America Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 16. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 17. Europe Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 18. MEA Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 19. North America Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 20. Global Non-Invasive Blood Glucose Monitoring Devices: by Type USD/Units (2013-2018)
  • Figure 21. Global Non-Invasive Blood Glucose Monitoring Devices share by Players 2018 (%)
  • Figure 22. Global Non-Invasive Blood Glucose Monitoring Devices share by Players (Top 3) 2018(%)
  • Figure 23. Global Non-Invasive Blood Glucose Monitoring Devices share by Players (Top 5) 2018(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 26. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 27. Medtronic Public Limited (United States) Revenue, Net Income and Gross profit
  • Figure 28. Medtronic Public Limited (United States) Revenue: by Geography 2018
  • Figure 29. Nemaura Medical, Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. Nemaura Medical, Inc. (United Kingdom) Revenue: by Geography 2018
  • Figure 31. Echo Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Echo Therapeutics, Inc. (United States) Revenue: by Geography 2018
  • Figure 33. Medical Wireless Sensing Ltd. (MediWiSe) (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Medical Wireless Sensing Ltd. (MediWiSe) (United Kingdom) Revenue: by Geography 2018
  • Figure 35. DexCom, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. DexCom, Inc. (United States) Revenue: by Geography 2018
  • Figure 37. Integrity Applications, Inc. (Israel) Revenue, Net Income and Gross profit
  • Figure 38. Integrity Applications, Inc. (Israel) Revenue: by Geography 2018
  • Figure 39. Cnoga Medical Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 40. Cnoga Medical Ltd (Israel) Revenue: by Geography 2018
  • Figure 41. LifeScan Inc. (Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 42. LifeScan Inc. (Johnson & Johnson (United States) Revenue: by Geography 2018
  • Figure 43. Global Non-Invasive Blood Glucose Monitoring Devices: by Type USD Million (2019-2024)
  • Figure 44. Global Non-Invasive Blood Glucose Monitoring Devices: by Application USD Million (2019-2024)
  • Figure 45. Global Non-Invasive Blood Glucose Monitoring Devices: by Modality USD Million (2019-2024)
  • Figure 46. South America Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 47. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 48. Europe Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 49. MEA Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 50. North America Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 51. Global Non-Invasive Blood Glucose Monitoring Devices: by Type K Units (2019-2024)
  • Figure 52. Global Non-Invasive Blood Glucose Monitoring Devices: by Application K Units (2019-2024)
  • Figure 53. Global Non-Invasive Blood Glucose Monitoring Devices: by Modality K Units (2019-2024)
  • Figure 54. South America Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 55. Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 56. Europe Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 57. MEA Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 58. North America Non-Invasive Blood Glucose Monitoring Devices Share (%), by Country
  • Figure 59. Global Non-Invasive Blood Glucose Monitoring Devices: by Type USD/Units (2019-2024)
List of companies from research coverage that are profiled in the study
  • Abbott Laboratories (United States)
  • Medtronic Public Limited (United States)
  • Nemaura Medical, Inc. (United Kingdom)
  • Echo Therapeutics, Inc. (United States)
  • Medical Wireless Sensing Ltd. (MediWiSe) (United Kingdom)
  • DexCom, Inc. (United States)
  • Integrity Applications, Inc. (Israel)
  • Cnoga Medical Ltd (Israel)
  • LifeScan Inc. (Johnson & Johnson (United States)
Additional players considered in the study are as follows:
Cercacor (United States) , OrSense Ltd. (Isreal) ,
Select User Access Type

Key Highlights of Report


Apr 2019 207 Pages 73 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Non-Invasive Blood Glucose Monitoring Devices Quantitative research analysis
Global Non-Invasive Blood Glucose Monitoring Devices Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Know More About Global Non-Invasive Blood Glucose Monitoring Devices Report?

Have a Query? Click Here

Other Related Reports

Spinal Non Fusion Technologies Comprehensive Study by Type (Dynamic stabilization devices, Disc nucleus replacement products, Annulus repair devices, Nuclear disc prostheses, Disc arthroplasty device...
$ 3800
Digital Mammography Equipment Comprehensive Study by Type (Analog Systems, Full Field Digital mammography (FFDM), Breast Tomosynthesis Systems), Technology (Screen Film, 2D Mammography, 3D Mammograph...
$ 3450
Orthopedic Splints Comprehensive Study by Type (Plaster Splints, Fiberglass Splints, Splinting Tools and Accessories, Other Splints), Application (Lower Extremity Splints, Upper Extremity Splints, Sp...
$ 3650
Implantable Cardioverter Defibrillator Comprehensive Study by Type (Single Chambered, Dual Chambered, Biventricular Implantable Cardioverter Defibrillators), End user (Hospitals, Ambulatory Surgical...
$ 3650
Patient Warming Device Comprehensive Study by Type (Surface Warming Systems, Intravascular Warming Systems, Patient Warming Accessories), Application (Acute Care, Perioperative Care, New Born Care), ...
$ 3650
Slit Lamp Microscope Comprehensive Study by Type (Handheld Slit Lamp Microscope, Benchtop Slit Lamp Microscope, Others), Application (Cornea Examination, Iris Examination, Crystalline Lens Examinatio...
$ 3800